CPRX Cash-Secured Put Strategy

CPRX (Catalyst Pharmaceuticals, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.

Catalyst Pharmaceuticals, Inc., founded in 2002 and based in Coral Gables, Florida, operates as a commercial-stage biopharmaceutical enterprise. This company is dedicated to discovering, developing, and marketing therapeutic solutions for individuals in the United States who are afflicted with uncommon, severe, and long-term neuromuscular and neurological disorders. Among its key offerings is Firdapse, an amifampridine phosphate tablet formulation approved for managing Lambert-Eaton Myasthenic Syndrome (LEMS). Catalyst also provides Ruzurgi, a specific treatment option for pediatric patients diagnosed with LEMS. Beyond its existing products, Catalyst is actively investigating additional applications for Firdapse, including its potential use in treating MuSK antibody positive myasthenia gravis, spinal muscular atrophy type 3, and hereditary neuropathy with liability to pressure palsies. The company engages in various strategic collaborations, such as licensing agreements with BioMarin Pharmaceutical Inc., and a joint development and commercialization agreement with Endo Ventures Limited concerning a generic version of Sabril tablets.

CPRX (Catalyst Pharmaceuticals, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $3.86B, a trailing P/E of 17.40, a beta of 0.74 versus the broader market, a 52-week range of 19.05-32.56, average daily share volume of 2.2M, a public-listing history dating back to 2006, approximately 181 full-time employees. These structural characteristics shape how CPRX stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 0.74 places CPRX roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.

What is a cash-secured put on CPRX?

A cash-secured put sells an out-of-the-money put while holding cash equal to the strike-times-100 obligation, keeping the premium when the underlying stays above the strike.

Current CPRX snapshot

As of June 30, 2026, spot at $31.45, ATM IV 34.40%, IV rank 30.68%, expected move 9.86%. The cash-secured put on CPRX below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 17-day expiry.

Why this cash-secured put structure on CPRX specifically: CPRX IV at 34.40% is mid-range versus its 1-year history, so the credit collected on a CPRX cash-secured put sits in line with its long-run distribution, with a market-implied 1-standard-deviation move of approximately 9.86% (roughly $3.10 on the underlying). The 17-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated CPRX expiries trade a higher absolute premium for lower per-day decay. Position sizing on CPRX should anchor to the underlying notional of $31.45 per share and to the trader's directional view on CPRX stock.

CPRX cash-secured put setup

The CPRX cash-secured put below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With CPRX near $31.45, the first option leg uses a $29.88 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed CPRX chain at a 17-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 CPRX shares for the stock leg in covered calls and collars).

ActionTypeStrike / BasisPremium (est)
Sell 1Put$29.88N/A

CPRX cash-secured put risk and reward

Net Premium / Debit
N/A
Max Profit (per contract)
Unbounded
Max Loss (per contract)
Unbounded
Breakeven(s)
None on modeled curve
Risk / Reward Ratio
N/A

Max profit equals premium times 100; max loss equals strike minus premium times 100 (at zero, assuming assignment). Breakeven is strike minus premium.

CPRX cash-secured put payoff curve

Modeled P&L at expiration across a range of underlying prices for the cash-secured put on CPRX. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

When traders use cash-secured put on CPRX

Cash-secured puts on CPRX earn premium while a trader waits to acquire CPRX stock at a target strike below the current quote; most attractive when IV is rich and the trader is comfortable owning CPRX.

CPRX thesis for this cash-secured put

The market-implied 1-standard-deviation range for CPRX extends from approximately $28.35 on the downside to $34.55 on the upside. A CPRX cash-secured put lets a trader earn premium while waiting to acquire CPRX at the strike price; the strategy is most attractive when the trader is comfortable holding the underlying at that level and IV is rich enough to compensate for the assignment risk. Current CPRX IV rank near 30.68% is mid-range against its 1-year distribution, so the IV signal is neutral; the cash-secured put thesis on CPRX should anchor more to the directional view and the expected-move geometry. As a Healthcare name, CPRX options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to CPRX-specific events.

CPRX cash-secured put positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. CPRX positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move CPRX alongside the broader basket even when CPRX-specific fundamentals are unchanged. Short-premium structures like a cash-secured put on CPRX carry tail risk when realized volatility exceeds the implied move; review historical CPRX earnings reactions and macro stress periods before sizing. Always rebuild the position from current CPRX chain quotes before placing a trade.

Frequently asked questions

What is a cash-secured put on CPRX?
A cash-secured put on CPRX is the cash-secured put strategy applied to CPRX (stock). The strategy is structurally neutral to slightly bullish: A cash-secured put sells an out-of-the-money put while holding cash equal to the strike-times-100 obligation, keeping the premium when the underlying stays above the strike. With CPRX stock trading near $31.45, the strikes shown on this page are snapped to the nearest listed CPRX chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are CPRX cash-secured put max profit and max loss calculated?
Max profit equals premium times 100; max loss equals strike minus premium times 100 (at zero, assuming assignment). Breakeven is strike minus premium. For the CPRX cash-secured put priced from the end-of-day chain at a 30-day expiry (ATM IV 34.40%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a CPRX cash-secured put?
The breakeven for the CPRX cash-secured put priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current CPRX market-implied 1-standard-deviation expected move is approximately 9.86%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a cash-secured put on CPRX?
Cash-secured puts on CPRX earn premium while a trader waits to acquire CPRX stock at a target strike below the current quote; most attractive when IV is rich and the trader is comfortable owning CPRX.
How does current CPRX implied volatility affect this cash-secured put?
CPRX ATM IV is at 34.40% with IV rank near 30.68%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.

Related CPRX analysis